• Microbot Medical entered an agreement with Lovell Government Services to target federal healthcare systems.
• Deal provides access to more than 2,000 government healthcare facilities, expanding the addressable U.S. customer base for its LIBERTY endovascular robotic system.
• Microbot also signed an agreement with Sanmina to establish a second manufacturing site to expand capacity for expected U.S. and international demand.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Microbot Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-037031), on August 11, 2026, and is solely responsible for the information contained therein.